Vasectomy access is a men’s health equity issue

In the months following the Dobbs decision in 2022, demand for vasectomies surged across multiple health systems, with some studies showing increases of over 200% in the three months after the ruling^1,2,3,4,5,6 .That shift tells us something important: when reproductive policy changes, men respond.

Nationally representative survey data underscore both engagement and unmet opportunity. Just over one in ten men ages 18 to 64 (11%) report having had a vasectomy, including 5% of men ages 18 to 25, and one in five (21%) men who have not had the procedure say they would consider getting one. Uptake varies by income and race: 13% of higher-income men report sterilization compared to 7% of lower-income men, and white men report four times higher rates than Black men. Knowledge gaps are also substantial, as only 34% of men correctly believe that most commercial insurance plans are not required to cover the full cost of vasectomy, while more than half (54%) say they do not know and 12% incorrectly believe this coverage is typically required. Together, these findings suggest that interest exists, but cost exposure, coverage confusion, and structural inequities shape who ultimately accesses care.

As Adam Sonfield noted in an AIBM policy paper, “Policy options to improve insurance coverage of vasectomy”:

There are multiple barriers to vasectomy use that may contribute to this disparity, including cultural attitudes about who should take responsibility for contraception and wider disparities affecting men’s access to and use of healthcare in the United States. But one clear hurdle is economic: Under current U.S. law, most privately insured women have coverage for contraception without any out-of-pocket costs, such as copayments, co-insurance, or deductibles. By contrast, these protections do not extend to privately insured men for vasectomy. This disparity in coverage sets up a clear economic incentive for couples to choose other contraceptive options over vasectomy, even when vasectomy might otherwise better fit their needs and preferences.

In his paper, Sonfield sets out a range of potential policy responses. Insurance design, Medicaid rules, and state-level variation continue to shape who can realistically access vasectomy, and at what cost. For organizations focused on advancing men’s health equity through pragmatic policy reform, vasectomy access, and men’s sexual and reproductive health more broadly, deserves a central place in the conversation.

The evidence: Demand is rising, barriers persist

A recent national survey data summarized by KFF shows that men cite fear of pain (39%) and cost (31%) as leading barriers to vasectomy consideration⁷. Cost concerns are not incidental—they are policy-driven.

Figure 1

Despite being one of the safest and most cost-effective permanent contraceptive methods, vasectomy is not guaranteed no-cost coverage under the Affordable Care Act’s preventive services mandate in the same way female contraception is⁸. This asymmetry sends a signal: male contraception is optional, not essential.

The problem extends further for men enrolled in High-Deductible Health Plans (HDHPs). In 2018, the IRS ruled that vasectomy does not qualify as preventive care for the purposes of Health Savings Account-eligible plans, effectively requiring even the small number of states that mandate no-cost vasectomy coverage to carve out HDHPs from their requirements. With roughly one in five covered workers enrolled in HDHPs with HSAs, this is not a minor gap. As Sonfield argues, correcting this IRS classification is one of the most immediately achievable federal reforms available—it requires only an administrative notice, not legislation.

Meanwhile, Medicaid policy adds additional friction. Every state Medicaid program is subject to a federally mandated 30-day waiting period for sterilization⁹. Originally designed to prevent coercion, this requirement now functions as a structural barrier.

This barrier does not operate in isolation. Clennon et al. (2025) report that nearly two-thirds of states have medium or difficult access to Medicaid-funded vasectomy, and men with incomes at or below 149% of the federal poverty level are five times less likely to undergo the procedure than higher-income men⁹. Because low-income individuals are disproportionately affected by unintended pregnancy and public programs bear higher downstream costs, restricting vasectomy access deepens inequities and increases fiscal strain on state Medicaid systems.

Abraham (2025) documents how the Medicaid sterilization consent process contributes to unfulfilled sterilization requests, literacy challenges, and inequitable access—particularly among low-income populations¹⁰. Modeling cited in that analysis suggests that reducing these barriers could substantially decrease unintended pregnancies and produce significant public cost savings.

The pattern is clear: men’s willingness to assume contraceptive responsibility is increasing, particularly in response to shifting reproductive policy. Yet state and federal coverage rules continue to create structural barriers that disproportionately burden low-income men and amplify inequities.

Geography should not determine reproductive agency

State-level variation compounds the problem. Clennon also found significant differences in Medicaid vasectomy access across states and a statistically significant relationship between restrictive abortion laws and barriers to Medicaid-funded vasectomy⁹.

In many states where abortion access is most restricted, Medicaid-covered vasectomy is also more difficult to obtain. These policy environments constrain women’s ability to avoid or manage unintended pregnancy while also limiting low-income men’s access to preventive options, reinforcing structural inequities.

Eight states—California, Illinois, Maryland, New Jersey, New Mexico, Oregon, Vermont, and Washington—have enacted requirements for state-regulated insurance plans to cover vasectomy without cost-sharing. This is a meaningful precedent, but it comes with a significant limitation: states can only regulate fully insured plans. Self-funded employer plans, which cover roughly 63% of workers with employer-sponsored insurance, are governed exclusively by federal law. Without federal action, the majority of privately insured men remain beyond the reach of even the most progressive state policies.

Policy priorities

Four pragmatic reforms could reduce these disparities:

1. Preventive coverage parity. Clarify that vasectomy qualifies for no-cost preventive coverage, aligning it with female contraception⁸.
2. Correct the IRS classification. Reclassify vasectomy as preventive care for HDHP purposes, removing the barrier that currently undermines state coverage mandates.
3. Modernize the Medicaid Consent process. Shorten or eliminate the 30-day waiting period while maintaining informed consent protections^9,10.
4. Expand state family planning benefits for men. Expand coverage via full-benefit Medicaid and/or Medicaid family planning eligibility expansions that include men and vasectomy, and avoid additional documentation barriers for sterilization⁹.

These reforms are administratively feasible and grounded in equity and cost-effectiveness.

Beyond legislative and regulatory channels, there is also an opportunity to engage the private sector directly. Business associations and health plan consultants have long made the financial case for comprehensive contraceptive coverage, including vasectomy. Encouraging insurers, third-party administrators, and large self-funded employers to voluntarily eliminate cost-sharing for vasectomy could extend coverage even where legislative action is stalled—and could create competitive pressure that shifts industry norms more broadly.

Policy can either enable or constrain responsibility

Vasectomy is safe, effective, and economical and demand is rising. The remaining obstacles are largely policy-created.

If policymakers want men to participate more fully in preventive health and shared reproductive responsibility, then insurance design and Medicaid policy must reflect that expectation.

Sound policy should identify structural barriers, evaluate the evidence, and pursue pragmatic reform. Vasectomy access is not a peripheral issue; expanding equitable access strengthens men’s health, supports couples in shared decision-making, promotes family stability, and contributes to healthier communities.

Dominick Shattuck

Dominick Shattuck, Ph.D., is an AIBM research fellow, community psychologist and public health researcher focused on improving the health of men and boys. He holds faculty appointments at the Johns Hopkins School of Medicine and the Bloomberg School of Public Health.